Evidence map›Paper›PMID 25964048›Full record

ArticlePharmaceutical research2015

Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.

SamiraSadat Abolmaali, AliMohammad Tamaddon, Eskandar Kamali-Sarvestani, MohammadJavad Ashraf, Rasoul Dinarvand

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Intraocular Implants for the Treatment of Autoimmune Uveitis.Journal of functional biomaterials · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

SamiraSadat AbolmaaliCenter for Nanotechnology in Drug Delivery, Department of Pharmaceutical Nanotechnology, Shiraz University of Medical Sciences, Shiraz, 71345, Iran. s.abolmaali@gmail.com.
AliMohammad TamaddonCenter for Nanotechnology in Drug Delivery, Department of Pharmaceutical Nanotechnology, Shiraz University of Medical Sciences, Shiraz, 71345, Iran. amtamadon@gmail.com.
Eskandar Kamali-SarvestaniAutoimmune Diseases Research Center and School of Medicine Department of Immunology, Shiraz University of Medical Sciences, Shiraz, 71345, Iran. immunol2@gmail.com.
MohammadJavad AshrafDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, 71345, Iran. Ashrafm@sums.ac.ir.
Rasoul DinarvandNanotechnology Research Centre and Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14174, Iran. dinarvand@tums.ac.ir.
Shiraz University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe study aimed to illustrate application of polycation Stealth nanogels for sustained delivery of methotrexate (MTX) in collagen induced arthritis (CIA) model in C57Bl/6 mice.

methodsNanogel synthesis involves metal ion coordinated self-assembly of PEGylated poly ethyleneimine (L-histidine substituted), chemical crosslinking and subsequent removal of the coordinated metal. The nanogels were characterized by TEM and DLS-zeta potential. Comparative efficacy and pharmacokinetics of the i.v. administred MTX-loaded nanogels were investigated in the CIA model. Inflammation site passive accumulation of the fluorophore-labeled nanogels was tested using in-vivo imaging of mice paw received unilateral injection of lipopolysaccharide.

resultsUniform nanogels (sizes ~40 nm by TEM) were loaded with MTX (entrapment efficiency = 62% and drug loading = 54% at the MTX feeding ratio of 0.3 relative to total molar concentration of the polymer amines). The nanogels exhibited neutral surface charge and an acceptable biocompatibility in terms of albumin aggregation, hemolysis, erythrocyte aggregation and cytotoxicity. Single dose pharmacokinetics of the MTX-loaded nanogels, unlike free drug, showed a sustained plasma profile. When arthritis established as confirmed by histopathology, a remarkable decline of paw swelling and clinical scores was observed. Fluorescence intensity of the nanogels was enhanced about 2.7 folds at the inflamed than control normal ankle.

conclusionSustained delivery of MTX and preferential accumulation of the nanogels in inflamed paw might explain the superior clinical outcome of the MTX-loaded nanogels.

Indexed as

AnimalsArthritis, ExperimentalAziridinesCollagenDrug CarriersDrug Delivery SystemsFemaleHistidineMethotrexateMiceMice, Inbred C57BLNanogelsPolyethylene GlycolsPolyethyleneiminePolymersaziridineAziridinesCollagenDrug CarriersHistidineMethotrexateNanogelspolyethylene glycol polyethyleneimine nanogelPolyethylene GlycolsPolyethyleneiminepolyhistidinePolymersclinical efficacycollagen induced arthritismethotrexatepharmacokineticsstealth nanogels

Identifiers

PMID25964048
OpenAlexW275071445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.